EUVIMEDEUVIMED entdecken
Crossref

Risk Stratification of a Novel Noninvasive Fibrosis Score in Metabolic Dysfunction-Associated Steatotic Liver Disease

Johnny T K Cheung, Xinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, Huapeng Lin, Guanlin Li, Howard Ho-Wai Leung, Jimmy Che-To Lai, Sanjiv Mahadeva, Nik Raihan Nik Mustapha, Xiao-Dong Wang, Wen-Yue Liu und 3 weitere

Clinical Gastroenterology and Hepatology · 2026-10 · 24 (10) · 2732-2741

DOI: 10.1016/j.cgh.2026.01.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Johnny T K Cheung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Primary Care, New Territories East Cluster, Hospital Authority, Hong Kong, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Fatty Liver, Severity of Illness Index. Die Arbeit nennt 26 Literaturangaben. Gefördert von: The Chinese University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Risk stratification in metabolic dysfunction-associated steatotic liver disease (MASLD) may identify high-risk groups for early intervention to reduce liver-related complications. We examined the prognostic accuracy of the MAFLD fibrosis score (MFS) in predicting risks of liver-related events and mortality among patients with MASLD. METHODS: This prospective cohort study with a median follow-up period of 9.7 years included 683 patients with biopsy-proven MASLD at 2 tertiary centers in Malaysia and Hong Kong. Noninvasive scores, including MFS, were computed using routine clinical data. Cumulative incidences of any liver-related events and all-cause mortality were compared between patients at low (MFS

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisFatty LiverSeverity of Illness IndexHumansMaleFemaleMiddle AgedProspective StudiesRisk AssessmentAdultHong KongMalaysiaPrognosisTertiary Care CentersAgedSurvival AnalysisIncidenceFollow-Up Studies

Stichwörter der Autor:innen

MAFLDMASHNAFLDSteatohepatitis

Autor:innen und Institutionen

  • Department of Family Medicine and Primary Care, New Territories East Cluster, Hospital Authority, Hong Kong, China.
  • Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, Palo Alto, California.
  • Department of Medicine and Therapeutics, Medical Data Analytics Centre, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese Unive…
  • Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China.
  • Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Department of Pathology, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia.

Förderung

  • The Chinese University of Hong Kong

Zitieren

APA

Cheung, J. T. K., Zhang, X., Wong, G. L., Yip, T. C., Lin, H., Li, G., Leung, H. H., Lai, J. C., Mahadeva, S., Nik Mustapha, N. R., Wang, X. D., Liu, W. Y., Chan, W. K., Zheng, M. H., & Wong, V. W. (2026). Risk Stratification of a Novel Noninvasive Fibrosis Score in Metabolic Dysfunction-Associated Steatotic Liver Disease. Clinical Gastroenterology and Hepatology, 24(10), 2732-2741. https://doi.org/10.1016/j.cgh.2026.01.035

Vancouver

Cheung JTK, Zhang X, Wong GL, Yip TC, Lin H, Li G, et al. Risk Stratification of a Novel Noninvasive Fibrosis Score in Metabolic Dysfunction-Associated Steatotic Liver Disease. Clinical Gastroenterology and Hepatology. 2026;24(10):2732-2741. doi:10.1016/j.cgh.2026.01.035

BibTeX
@article{Cheung2026,
  author = {Cheung, Johnny T K and Zhang, Xinrong and Wong, Grace Lai-Hung and Yip, Terry Cheuk-Fung and Lin, Huapeng and Li, Guanlin and Leung, Howard Ho-Wai and Lai, Jimmy Che-To and Mahadeva, Sanjiv and Nik Mustapha, Nik Raihan and Wang, Xiao-Dong and Liu, Wen-Yue and Chan, Wah-Kheong and Zheng, Ming-Hua and Wong, Vincent Wai-Sun},
  title = {Risk Stratification of a Novel Noninvasive Fibrosis Score in Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {10},
  pages = {2732--2741},
  doi = {10.1016/j.cgh.2026.01.035}
}
Kostenlos starten →